COVID-19: Transmission, prevention, and potential therapeutic opportunities

By Melika Lotfi, Michael R Hamblin, Nima Rezaei. Clinica chimica acta; international journal of clinical chemistry, 2020

815 citations recorded by the source corpus.

Highlights • Novel coronavirus disease (COVID-19) is a global issue nowadays.• COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).• The current knowledge about the treatment protocol is still limited.• Preventing the virus can be the best way of controlling the pandemic.

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/4653b13b77da785f6ada4f831b2742e8b34a4d63

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Huang
2. F. Zhou
3. O. Chang
4. C. Y. Wong
5. Jiawen Deng
6. Q. Zuo
7. W. Hou
8. Z. Silver

Citations in the corpus

• The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis (2020, methodology): “The data extraction form included the following items: (1) author names, (2) study title, (3) publication date, (4) digital object identifier, (5) country of origin, (6) study design, (7) sample size, (8) questionnaire response rate, (9) patient demographics (i.”